Biomarin Pharmaceutical Inc

SUSQUEHANNA INTERNATIONAL GROUP, LLP BMRN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

139,210

Value ($000)

8,273

Weight

0.0%

2013 Q4 - 2025 Q4 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	8,273	0.0%	139,210	12/31/2025
2025 Q3	11/14/2025	9,857	0.0%	181,994	9/30/2025
2025 Q2	8/14/2025	873	0.0%	15,878	6/30/2025
2025 Q1	5/14/2025	6,467	0.0%	91,480	3/31/2025
2024 Q4	2/14/2025	5,980	0.0%	90,974	12/31/2024
2024 Q3	11/14/2024	7,741	0.0%	110,123	9/30/2024
2024 Q2	8/15/2024	3,053	0.0%	37,078	6/30/2024
2024 Q1	5/7/2024	59,102	0.1%	676,686	3/31/2024
2023 Q4	2/14/2024	25,027	0.0%	259,558	12/31/2023
2023 Q3	11/14/2023	27,849	0.0%	314,748	9/30/2023
2023 Q2	8/11/2023	37,921	0.1%	437,478	6/30/2023
2023 Q1	5/16/2023	33,831	0.1%	347,915	3/31/2023
2022 Q4	2/14/2023	19,959	0.0%	192,855	12/31/2022
2022 Q3	11/14/2022	23,154	0.0%	273,137	9/30/2022
2022 Q2	8/15/2022	720	0.0%	8,682	6/30/2022
2022 Q1	5/16/2022	7,410	0.0%	96,111	3/31/2022
2021 Q4	2/14/2022	10,629	0.0%	120,305	12/31/2021
2021 Q3	11/15/2021	17,189	0.0%	222,395	9/30/2021
2021 Q2	8/11/2021	10,500	0.0%	125,835	6/30/2021
2021 Q1	5/17/2021	31,863	0.0%	421,975	3/31/2021
2020 Q4	2/16/2021	31,935	0.0%	364,184	12/31/2020
2020 Q3	11/16/2020	15,670	0.0%	205,967	9/30/2020
2020 Q2	8/14/2020	19,842	0.0%	160,871	6/30/2020
2020 Q1	5/15/2020	17,977	0.0%	212,744	3/31/2020
2019 Q4	2/14/2020	50,376	0.1%	595,814	12/31/2019
2014 Q1	5/14/2014	2,648	0.0%	38,827	3/31/2014
2013 Q4	2/13/2014	7,782	0.0%	110,738	12/31/2013